-
No yield, too few bunds - what investment trials mean for 2020 Review
03 April 2020Frank Schiller, board member of the DAV, tells David Walker in a far ranging interview his thoughts on the 2020 Solvency II review and where he believes EIOPA needs to step up its work.
-
SII reporting delays: thanks but no thanks
01 April 2020As European regulators offer some leeway on Solvency II regulatory reporting deadlines, insurers seem inclined to follow the original schedule. Begging the question of how to account for the COVID-19 impact. David Walker reports
-
China's insurance giants divulge the finer details of investment outsourcing
30 March 2020Could European underwriters have a thing or two to learn from their Chinese counterparts when it comes to transparency in their reporting? David Walker takes a closer look
-
Insurers advised to stay put with EM holdings amid COVID-19 chaos
25 March 2020With lower ratings than their developed market counterparts and potential economic dependencies to oil, emerging markets are on the frontline of the COVID-19 crisis. It is raising questions for insurers' allocation to the asset class. Vincent Huck reports
-
Risk Management in times of the Global Coronavirus Crisis
23 March 2020Jegor Tokarevich and Amirlan Seksenbayev from Substance Over Form, look at the risks posed by COVID-19 to insurance investors and how they can mitigate them to make the most of the opportunities arising.
-
Coronavirus slump: the good, the bad and the ugly
19 March 2020Not a single day passes without some new market revelation. Insurers are battening down the hatches but how bad is it and what damage has there been so far? Sarfraz Thind presents the good, the bad and the ugly of the market crash.
-
The Secret CIO on COVID-19
16 March 2020As markets sink, a chief investment officer at a European insurer tells Vincent Huck how the pandemic is affecting its thinking.
-
When China sneezes, Europe's insurers catch the cold
11 March 2020Analysis by Insurance Risk Data shows most countries' underwriters were adding equities in general accounts as virus risk approached. David Walker reports
-
Insurers' affiliates outperforming independent managers on ESG
10 March 2020Half of the world's largest asset managers are neglecting the ecological and social harms of their investments, according to a research by ShareAction. However, insurers' affiliates seem to be ahead of the curve. Vincent Huck reports
-
Personal take on insurance investing in the context of Solvency II's 2020 review
05 March 2020Carlos Montalvo Rebuelta reflects on what we should expect from the Solvency II 2020 review based on past amendments of the Directive. So good or bad news?
- Hanwha Life gets US financial sector foothold with acquisition
- Aegon UK's head of responsible investment steps down
- Insurers eyeing private markets, Schroders survey finds
- Gresham House appoints director of global natural capital
- Tokio Marine steps up strategic equity sell-down plans
- SLAM acquires London care home for £11.25m
- Private credit markets hit $3trn, report finds
- Investments blow tailwinds in three MS&AD units, in 1H results
- AEW acquires logistics asset near Frankfurt
- Complacency is key risk to watch for, Swiss Re's Haegeli warns